These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1443042)

  • 1. Interleukin-4 may contribute to the abundant T-cell reaction and paucity of neoplastic B cells in T-cell-rich B-cell lymphomas.
    Macon WR; Cousar JB; Waldron JA; Hsu SM
    Am J Pathol; 1992 Nov; 141(5):1031-6. PubMed ID: 1443042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma.
    Takeshita M; Sumiyoshi Y; Masuda Y; Ohshima K; Yoshida T; Kikuchi M; Müller H
    Pathol Res Pract; 1993 Feb; 189(1):18-25. PubMed ID: 8516212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas.
    Felgar RE; Steward KR; Cousar JB; Macon WR
    Am J Pathol; 1998 Dec; 153(6):1707-15. PubMed ID: 9846961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
    Hsu SM; Xie SS; Hsu PL; Waldron JA
    Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases.
    Macon WR; Williams ME; Greer JP; Stein RS; Collins RD; Cousar JB
    Am J Surg Pathol; 1992 Apr; 16(4):351-63. PubMed ID: 1373580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: two closely related entities?
    Schmidt U; Metz KA; Leder LD
    Br J Haematol; 1995 Jun; 90(2):398-403. PubMed ID: 7794762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169- monocyte-derived cells in diffuse large B-cell lymphomas.
    Marmey B; Boix C; Barbaroux JB; Dieu-Nosjean MC; Diebold J; Audouin J; Fridman WH; Mueller CG; Molina TJ
    Hum Pathol; 2006 Jan; 37(1):68-77. PubMed ID: 16360418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].
    Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ
    Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M; Raziuddin S
    J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine malignant lymphomas: morphologic and immunohistochemical classification.
    Kelley LC; Mahaffey EA
    Vet Pathol; 1998 Jul; 35(4):241-52. PubMed ID: 9684967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous T-cell-rich B-cell lymphoma. A case report with a 13-year follow-up.
    Dommann SN; Dommann-Scherrer CC; Zimmerman D; Dours-Zimmermann MT; Hassam S; Burg G
    Am J Dermatopathol; 1995 Dec; 17(6):618-24. PubMed ID: 8599480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological variability of tumour cells in T-cell-rich B-cell lymphoma. A histopathological study of 14 cases.
    Camilleri-Bröet S; Molina T; Audouin J; Tourneau AL; Diebold J
    Virchows Arch; 1996 Nov; 429(4-5):243-8. PubMed ID: 8972760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma.
    Yamaguchi S; Kitagawa M; Inoue M; Tomizawa N; Kamiyama R; Hirokawa K
    Exp Mol Pathol; 2000 Apr; 68(2):85-94. PubMed ID: 10716912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study.
    Nguyen DT; Diamond LW; Hansmann ML; Fischer R
    Hematopathol Mol Hematol; 1996; 10(3):135-50. PubMed ID: 8878732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas ligand expression in nodal non-Hodgkin's lymphoma.
    Müllauer L; Mosberger I; Chott A
    Mod Pathol; 1998 Apr; 11(4):369-75. PubMed ID: 9578088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
    Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
    Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell rich B cell lymphoma (TCRBCL): study of sixteen cases with review of literature.
    Muzaffar S; Pervez S; Kayani N; Soomro IN; Hasan SH
    Indian J Pathol Microbiol; 1999 Jan; 42(1):15-23. PubMed ID: 10420680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 4 and gamma-interferon may play a role in the histopathogenesis of peripheral T-cell lymphoma.
    Ohnishi K; Ichikawa A; Kagami Y; Nagasaka T; Niwa T; Hotta T; Saito H
    Cancer Res; 1990 Dec; 50(24):8028-33. PubMed ID: 2123745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.